Innovative Solutions for Life Science Challenges
Scientific Experience
Genetic, molecular, cellular & tissue engineering
Molecular mechanisms and pathogenesis of viruses, vaccine
development, adjuvants, and antibody engineering & production
Professional Experience
Stephen Hall, PhD
Biodefense Consulting
1998-present
Stephen Hall, PhD, Ltd
Founder, CEO & CSO
1998-2023
Antibody & Biomaterial Development
(Acquired by Janel Corporation in 2023)
Pentamer Pharmaceuticals, Inc
Founder, CEO & CSO
1997-2002
Vaccine Development
(Acquired by Johnson & Johnson in 2002)
Education
Postdoctoral Research Associate, The Scripps Research Institute
1995-1997
Molecular and Structural Virology
Research Fellow, Medical Biology Institute
(now Avanir Pharmaceuticals)
1996-1997
Cancer Immunology
Ph.D., Purdue University
1995
Molecular & Cellular Biology
(American Cancer Society Fellow)
B.S., Grand Canyon University
1990
Chemistry
Contact Me
This website uses cookies.
We use cookies to analyze website traffic and optimize your website experience. By accepting our use of cookies, your data will be aggregated with all other user data.